Unknown

Dataset Information

0

Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.


ABSTRACT: Bacillus anthracis remains a serious bioterrorism concern, and the currently licensed vaccine remains an incomplete solution for population protection from inhalation anthrax and has been associated with concerns regarding efficacy and safety. Thus, understanding how to generate long-lasting protective immunity with reduced immunizations or provide protection through postexposure immunotherapeutics are long-sought goals. Through evaluation of a large military cohort, we characterized the levels of antibodies against protective antigen and found that over half of anthrax vaccinees had low serum levels of in vitro toxin neutralization capacity. Using solid-phase epitope mapping and confirmatory assays, we identified several neutralization-associated humoral epitopes and demonstrated that select antipeptide responses mediated protection in vitro. Finally, passively transferred antibodies specific for select epitopes provided protection in an in vivo lethal toxin mouse model. Identification of these antigenic regions has important implications for vaccine design and the development of directed immunotherapeutics.

SUBMITTER: Crowe SR 

PROVIDER: S-EPMC2891133 | biostudies-literature | 2010 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.

Crowe Sherry R SR   Ash Linda L LL   Engler Renata J M RJ   Ballard Jimmy D JD   Harley John B JB   Farris A Darise AD   James Judith A JA  

The Journal of infectious diseases 20100701 2


Bacillus anthracis remains a serious bioterrorism concern, and the currently licensed vaccine remains an incomplete solution for population protection from inhalation anthrax and has been associated with concerns regarding efficacy and safety. Thus, understanding how to generate long-lasting protective immunity with reduced immunizations or provide protection through postexposure immunotherapeutics are long-sought goals. Through evaluation of a large military cohort, we characterized the levels  ...[more]

Similar Datasets

| S-EPMC1307059 | biostudies-literature
| S-EPMC1986636 | biostudies-literature
| S-EPMC5512426 | biostudies-literature
| S-EPMC6249563 | biostudies-literature
| S-EPMC2663156 | biostudies-literature
| S-EPMC3668972 | biostudies-literature
| S-EPMC1617126 | biostudies-literature
| S-EPMC5934503 | biostudies-literature
| S-EPMC5666345 | biostudies-literature
| S-EPMC7012834 | biostudies-literature